ConductScience.org, home

Library / Trials

First Pass Spectral Perfusion From Photon Counting CT

NCT07925151, Enrolling by invitation, Medical University of Silesia

Trial 8

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleFirst Pass Spectral Perfusion From Photon Counting CTClinicalTrials.gov
NCT numberNCT07925151ClinicalTrials.gov
StatusEnrolling by invitationClinicalTrials.gov
Enrollment200 participants, estimatedClinicalTrials.gov
Lead sponsorMedical University of SilesiaClinicalTrials.gov
ConditionsCoronary Arterial Disease, Myocardial Perfusion Imaging, Chronic Total Occlusion (CTO)ClinicalTrials.gov
First posted2026-11-09ClinicalTrials.gov
Last updated2026-11-12ClinicalTrials.gov

Registered outcomes 1

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
Primary
Diagnostic performance of spectral coronary computed tomography angiography (CCTA) for the detection of myocardial perfusion defects in patients with chronic total occlusion (CTO) of the coronary arteries.
20 months
To evaluate the ability of spectral CCTA to identify myocardial perfusion defects in the myocardial territory supplied by a CTO vessel, using an appropriate reference standard for myocardial perfusion assessment, and an automatic method for tissue analysis. The study will investigate whether spectral CCTA can provide an integrated, one-stop assessment of coronary anatomy and myocardial perfusion.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)